About this Calculator

The Cisplatin Dose Calculator (BSA-based) is a clinical support tool designed for healthcare professionals to determine the total dose of cisplatin for a patient based on their Body Surface Area (BSA). BSA-based dosing is a standard practice in oncology to normalize chemotherapy doses relative to patient size. This method aims to optimize therapeutic efficacy while minimizing toxicity.

Outputs Explained

After entering the required patient data, the calculator provides two key outputs:

• Body Surface Area (BSA): The patient’s estimated BSA, calculated in square meters (m²), using the selected empirical formula (e.g., Mosteller, Du Bois).
• Total Cisplatin Dose: The final calculated dose in milligrams (mg) to be administered for a single treatment. This value is the product of the prescribed dose (in mg/m²) and the patient’s BSA.

How to Use the Calculator

To ensure an accurate dose calculation, follow these steps:

1. Enter Patient Height: Input the patient’s height and select the correct unit (centimeters or inches).
2. Enter Patient Weight: Input the patient’s weight and select the correct unit (kilograms or pounds).
3. Select BSA Formula: Choose the desired formula for BSA calculation from the dropdown menu. The Mosteller formula is a common default due to its simplicity and accuracy.
4. Enter Prescribed Dose: Input the dose of cisplatin as prescribed by the treatment protocol, specified in mg/m².
5. Consider Dose Capping: Check the box to apply a dose cap if institutional policy requires limiting the BSA used for calculation to 2.0 m², a common practice to prevent excessive toxicity in larger patients.

Cisplatin Dosing Overview

Cisplatin is a platinum-based antineoplastic agent used in various combination chemotherapy regimens. Dosing is highly dependent on the type of cancer, treatment protocol, and patient-specific factors like renal function and performance status. A typical dose can range from 20 mg/m² to 120 mg/m² per cycle. Aggressive pre- and post-treatment hydration is critical to mitigate the risk of nephrotoxicity, a primary dose-limiting side effect.

Switching Treatment

Any decision to switch from cisplatin to another chemotherapy agent (e.g., carboplatin) or to alter a treatment regimen must be made by a qualified oncologist. Switching may be considered due to severe toxicities, disease progression, or changes in clinical guidelines. This calculator should not be used for dose conversion between different drugs; for example, carboplatin dosing is calculated using the Calvert formula, which is based on renal function (GFR).

Managing a Missed Dose

Chemotherapy administration follows a strict dosing schedule to maximize its effectiveness. If a patient misses a scheduled infusion of cisplatin, the oncology care team must be contacted immediately for instructions. Patients should be advised not to wait until the next planned cycle. The clinical team will determine the best course of action based on the treatment plan and the patient’s condition.

Safety Alerts & Clinical Considerations

Cisplatin has a narrow therapeutic index and is associated with significant toxicities that require careful monitoring:

• Nephrotoxicity: Severe kidney damage is a major risk. Renal function (serum creatinine, creatinine clearance) must be assessed before each cycle.
• Ototoxicity: Cisplatin can cause irreversible hearing loss, particularly at high frequencies. Audiometric testing may be required.
• Neurotoxicity: Peripheral neuropathy is common and can be cumulative and dose-dependent.
• Myelosuppression: Suppression of bone marrow function can lead to anemia, neutropenia, and thrombocytopenia.
• Severe Nausea and Vomiting: Cisplatin is highly emetogenic; aggressive antiemetic prophylaxis is standard practice.

Frequently Asked Questions (FAQ)

Why are there different BSA formulas to choose from?

Several formulas have been developed over the years to estimate BSA. While they generally produce similar results in average-sized adults, they can vary in pediatric patients or individuals at the extremes of height and weight. The Mosteller formula is widely used for its simplicity and reliability.

What does the “Apply dose cap for BSA > 2.0 m²” option do?

This is a safety feature used by many institutions to prevent potentially excessive and toxic doses in patients with a high BSA. When checked, if the calculated BSA is over 2.0 m², the calculator will use exactly 2.0 m² to determine the final dose, effectively “capping” the maximum dose administered.

What happens if I enter a very high or low height or weight?

The tool is designed to show a warning for values outside of a typical physiological range (e.g., weight < 20 kg or > 300 kg). This prompts the user to double-check their input for potential typos to ensure patient safety.

Can I use this calculator for carboplatin dosing?

No. Carboplatin dosing is fundamentally different and is calculated using the Calvert formula, which relies on the target Area Under the Curve (AUC) and the patient’s Glomerular Filtration Rate (GFR), not BSA.

Does this calculator account for renal impairment?

No. The calculator determines a dose based on body size only. Cisplatin doses must be adjusted or held based on the patient’s renal function (e.g., creatinine clearance). This requires separate clinical assessment and adherence to institutional protocols.

What is a typical prescribed cisplatin dose?

Doses vary widely by cancer type and protocol. For single-agent therapy, doses of 50-120 mg/m² every 3-4 weeks are common. In combination regimens, doses are often lower, such as 20 mg/m² daily for several days.

Why is the prescribed dose in mg/m²?

Dosing by BSA (mg/m²) is a standard in oncology that attempts to scale drug dosage to a patient’s metabolic mass more accurately than weight-based dosing (mg/kg), theoretically leading to more consistent drug exposure and response.

Who is this tool intended for?

This tool is intended for use by licensed healthcare professionals, such as oncologists, pharmacists, and nurses, for informational and educational purposes. It is not a substitute for professional clinical judgment.